Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

VitaNova Life Sciences (YJGJ) Non Operating Income (2021 - 2025)

VitaNova Life Sciences (YJGJ) has disclosed Non Operating Income for 3 consecutive years, with -$1568.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non Operating Income fell 1593.33% year-over-year to -$1568.0, compared with a TTM value of -$3905.0 through Apr 2025, down 102.55%, and an annual FY2025 reading of -$4010.0, down 3919.05% over the prior year.
  • Non Operating Income was -$1568.0 for Q2 2025 at VitaNova Life Sciences, down from -$617.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $153049.0 in Q3 2021 and bottomed at -$1825.0 in Q4 2024.
  • Average Non Operating Income over 3 years is $29828.8, with a median of -$617.0 recorded in 2025.
  • Peak annual rise in Non Operating Income hit 1593.33% in 2025, while the deepest fall reached 1593.33% in 2025.
  • Year by year, Non Operating Income stood at $153049.0 in 2021, then plummeted by 101.19% to -$1825.0 in 2024, then rose by 14.08% to -$1568.0 in 2025.
  • Business Quant data shows Non Operating Income for YJGJ at -$1568.0 in Q2 2025, -$617.0 in Q1 2025, and -$1825.0 in Q4 2024.